Molecular Signature of Inactivity Induced Exercise Responsiveness
1 other identifier
interventional
11
1 country
1
Brief Summary
Fitness is one of the best predictors for heart and brain disease. To increase ones fitness, the American Heart Association (AHA) says to exercise at least 150 minutes per week or 75 minutes per week if really hard. These exercise guides are pretty effective, however not everyone will get the same results. What individuals do outside of the exercise bout can influence the effectiveness of exercise. One of these factors is our time sitting, which has caused the phrase "sitting is the new smoking". Other studies have said that the metabolic benefits of exercise are decreased when you exercise after a few days of low activity (less than 5,000 steps per day). This is important in that exercise may not be able to fully offset these times of inactivity. However, these studies were only looking at different fats in the blood. As exercise increases fat burn up to 10 times in the muscle, more research is needed to understand how inactivity affects the muscle during exercise and after exercise. This study will help answer two questions: 1) How does a day of sitting a lot affect the muscle's ability to respond to exercise? and 2) How does a day of sitting a lot affect carbohydrate and fat burn during and after a bout of exercise? The investigators will answer these questions by having people complete one day of inactivity (less than 5,000 steps) or normal activity (more than 8,500 steps). Subjects will then come in the next day to bike somewhat hard for 1 hour. The investigators will take blood samples before, during, and after exercise to measure energy sources. The investigators will also collect pieces of skeletal muscle before and after exercise to see how the muscle responded to exercise. This study is significant for the publication of exercise guidelines to minimize risk of heart and metabolic diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
February 29, 2024
CompletedFirst Posted
Study publicly available on registry
March 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedFebruary 19, 2026
February 1, 2026
2 years
February 29, 2024
February 17, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Circulating lipid and carbohydrate metabolism
Investigate the role of sex and inactivity on lipid and carbohydrate metabolism following a bout of aerobic exercise.
Baseline; 20 and 40, and 60 minutes into exercise; and every 30 minutes after exercise up to 4 hours
Basal and post-exercise gene expression with inactivity
Study the role of inactivity on basal and exercise-induced gene expression in skeletal muscle.
Baseline; 4 hours after exercise
Study Arms (2)
Inactive
EXPERIMENTALSubjects will be asked to be sedentary prior to an acute exercise bout (\<5,000 steps as measured by a physical activity monitor).
Normal activity
PLACEBO COMPARATORSubjects will be asked to have normal activity prior to an acute exercise bout (\>8,500 steps as measured by a physical activity monitor).
Interventions
Low physical activity level prior to the exercise intervention.
Eligibility Criteria
You may qualify if:
- free from acute or chronic illness (cardiac, pulmonary, liver, or kidney abnormalities, cancer, uncontrolled hypertension, insulin- or non-insulin dependent diabetes or other known metabolic disorders)
- free from orthopedic limitations (including any artificial joints) no known lidocaine allergy
- do not currently smoke or participate in other forms of tobacco use.
- not currently in a structured exercise program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kevin J Gries
Mequon, Wisconsin, 53092, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 29, 2024
First Posted
March 8, 2024
Study Start
January 1, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
February 19, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share